Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It

Mantle cell lymphoma (MCL) is a relatively rare

Biovest International, makers of the personalized therapeutic lymphoma vaccine BiovaxID, have

Next up in the Leukemia & Lymphoma Society's free telephone/web education programs

The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta,

The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood

Changing R-CHOP improved outcomes in patients with mantle cell lymphoma (MCL), according

At the recent ASH meeting in San Diego, researchers from Italy presented data supporting the use

Janssen has applied to the European Medicines Agency (EMA) to expand the label for

Andrew Madoff was the only surviving son of Bernie Madoff, whose notorious Ponzi scheme

Specialty biopharmaceutical company Biovest

According to the manufacturer, Velcade (bortezomib) has been approved by the US FDA in